tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rakovina Therapeutics to Host Webinar on AI-Driven Cancer Therapies
PremiumCompany AnnouncementsRakovina Therapeutics to Host Webinar on AI-Driven Cancer Therapies
2M ago
Rakovina Therapeutics Reports Q3 2025 Financial Results and Highlights Strategic Advances
Premium
Company Announcements
Rakovina Therapeutics Reports Q3 2025 Financial Results and Highlights Strategic Advances
3M ago
Rakovina Therapeutics Secures Debenture Extension Amid Expired Warrant Program
Premium
Company Announcements
Rakovina Therapeutics Secures Debenture Extension Amid Expired Warrant Program
3M ago
Rakovina Therapeutics Unveils AI-Developed ATR Inhibitors with CNS Penetration
PremiumCompany AnnouncementsRakovina Therapeutics Unveils AI-Developed ATR Inhibitors with CNS Penetration
4M ago
Rakovina Therapeutics to Present Groundbreaking ATR Inhibitor Data at International Conference
Premium
Company Announcements
Rakovina Therapeutics to Present Groundbreaking ATR Inhibitor Data at International Conference
4M ago
Rakovina Therapeutics to Present at Global Investment Conference Amidst Strategic Advances
Premium
Company Announcements
Rakovina Therapeutics to Present at Global Investment Conference Amidst Strategic Advances
6M ago
Rakovina Therapeutics Grants Stock Options to Propel AI-Powered Cancer Therapy Development
PremiumCompany AnnouncementsRakovina Therapeutics Grants Stock Options to Propel AI-Powered Cancer Therapy Development
7M ago
Rakovina Therapeutics Launches Warrant Exercise Incentive Program
Premium
Company Announcements
Rakovina Therapeutics Launches Warrant Exercise Incentive Program
7M ago
Rakovina Therapeutics Advances AI-Driven ATR Inhibitor Program
Premium
Company Announcements
Rakovina Therapeutics Advances AI-Driven ATR Inhibitor Program
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100